Mechanism
How Dornase Alfa works
Recombinant human DNase that cleaves extracellular DNA in airway secretions, reducing mucus viscosity and improving secretion clearance.
← Respiratory Pharmacology
MUCNBRC High Yield5/5 Importance
Dornase Alfa Respiratory Pharmacology Guide
The complete learning guide for class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style respiratory pharmacology.
Dornase alfa is a recombinant DNase used mainly in cystic fibrosis. It cleaves extracellular DNA from inflammatory cells within airway secretions, reducing mucus viscosity and improving clearance. For NBRC-style questions, distinguish dornase alfa from N-acetylcysteine: dornase breaks DNA, while NAC breaks disulfide bonds.
Clinical Pharmacology
Understand the medication before memorizing it
Start with mechanism, clinical pearls, onset, peak, duration, and deeper pharmacology explanations so the rest of the page has context.
Clinical Pearl
What to remember
The classic distinction: NAC breaks disulfide bonds; dornase alfa breaks extracellular DNA in CF secretions.
Kinetics
Onset, peak, and duration
1
Onset
Days to weeks
2
Peak
Variable
3
Duration
Maintenance therapy
Clinical Practice
How this medication is used at the bedside
Review common indications, expected adverse effects, contraindications, cautions, and safety issues in a clinically useful order.
Quick facts
- Subclass
- Mucolytic / DNase
- NBRC importance
- 5/5
- Difficulty
- 3/5
- Brands
- Pulmozyme
5/5
NBRC importance
12
Study facts
0
Practice questions
2026
Updated
Common indications
- Cystic fibrosis with thick secretions
- Airway secretion clearance in CF
- Reduction of pulmonary exacerbation risk in CF
Adverse effects
- Voice alteration
- Hoarseness
- Pharyngitis
- Laryngitis
- Rash
- Chest discomfort
Contraindications
- Hypersensitivity to dornase alfa or formulation components
Cautions and safety issues
- Primarily used in cystic fibrosis
- Do not mix with other nebulized medications in the same nebulizer cup unless specifically directed
RT & NBRC Mastery
Respiratory therapy exam and bedside mastery
Move from reference knowledge into board-style reasoning, adaptive practice, common distractors, and high-yield clinical scenarios.
NBRC-style question
NBRC-style pharmacology review
A patient scenario involves cystic fibrosis patient with thick secretions. Which medication concept should the respiratory therapy student recognize?
High-yield answer
Dornase = DNase for CF
Interactive practice
The Adaptive Exam Simulator
Use the complete guide on this page to learn the medication, then switch into the adaptive simulator to test yourself with scored practice, missed-concept review, and NBRC-style clinical reasoning.
ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Common Exam Traps
These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.
- Breaks disulfide bonds
- Beta-2 agonist
- Muscarinic antagonist
- Inhaled corticosteroid
- Pulmonary vasodilator
High-Yield Clinical Scenarios
- Cystic fibrosis patient with thick secretions
- Question comparing NAC versus dornase alfa
- Airway clearance therapy in CF
Guidelines
Guideline-based clinical context
Connect medication facts to the larger respiratory care guidelines, disease-state recommendations, and clinical decision frameworks.
Study Tools
Practice, recall, and retention
Use mini cases, flashcards, FAQs, and related concepts to turn the medication page into a high-retention study experience.
Practice Questions
Complete question bank
Work through 0 board-style and clinical reasoning questions for this medication, organized by concept area.
Related study paths
Continue building pharmacology mastery
Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.